7 Notable Companies Empowering Women’s Health with AI
With over half of the world's population being female, it's only natural that the world of femtech is experiencing a …
Biopharma Insights
9 Notable AI Companies in Clinical Research to Watch in 2023
The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% …
AI Breaches the Barrier Towards Better CNS Drug Discovery
The sphere of oncology continues to grapple with the complex nature of brain and central nervous system (CNS) tumors. Data …
Biopharma Industry Review: A Year of Challenges and Changes in 2023
The biopharma industry experienced a challenging year in 2023, marked by a significant decrease in funding and a high number …
The Rising Popularity of Antibody-Drug Conjugates, with Challenges
In the current climate of global economic uncertainty, one area of pharmaceutical development is bucking the trend with a significant …
Addressing Inequity in Medical Research: The Need to Expand Genomic Databases
Precision medicine is fast developing, with genomics being a particularly promising field. As genomic medicine advances, we get steadily closer …
Tech-First Companies Take the Lead in AI Drug Discovery
In recent news, Recursion (NASDAQ: RXRX), a prominent clinical stage TechBio firm, has announced the signing of agreements to acquire …
Insilico Medicine’s Generative AI Patent Provides Advantage in AI Drug Discovery Race
Companies are increasingly turning to generative artificial intelligence (AI) to develop new therapeutics, giving biotech companies with patents on these …
Eight Approaches to Leveraging AI in Clinical Trials with the Key Industry Innovators
In the ongoing pursuit of new drugs and medical treatments, the pharmaceutical sector faces a complex task: verifying the safety …
Maturing Pharma 4.0: How Digital Transformation Continues To Reshape Pharmaceuticals
The digital transformation of biopharmaceutical manufacturing has continued at a rapid pace as companies mine the rich sources of data …
Will Biologics Surpass Small Molecules In The Pharmaceutical Race?
The first biologics drug, humanized insulin (5.8 kDa), became available in 1982 following the advent of biotechnology, and it marked …
From Gene Editing to Pathway Design: How AI is Transforming Synthetic Biology
It is hard to overestimate the potential of biotechnology to address some of the most pressing challenges of the 21st …